These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19489106)

  • 1. Epigallocatechin-3-gallate affects the growth of LNCaP cells via membrane fluidity and distribution of cellular zinc.
    Yang JG; Yu HN; Sun SL; Zhang LC; He GQ; Das UN; Ruan H; Shen SR
    J Zhejiang Univ Sci B; 2009 Jun; 10(6):411-21. PubMed ID: 19489106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of free Zn(2+) enhancing inhibitory effects of EGCG on the growth of PC-3 cells: interactions with mitochondria.
    Yang J; Yu H; Sun S; Zhang L; Das UN; Ruan H; He G; Shen S
    Biol Trace Elem Res; 2009 Dec; 131(3):298-310. PubMed ID: 19326061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of epigallocatechin-3-gallate to LNCaP cells in the presence of Cu2+.
    Yu HN; Shen SR; Xiong YK
    J Zhejiang Univ Sci B; 2005 Feb; 6(2):125-31. PubMed ID: 15633248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interactions of EGCG and Cd(2+) on the growth of PC-3 cells and their mechanisms.
    Yu HN; Shen SR; Yin JJ
    Food Chem Toxicol; 2007 Feb; 45(2):244-9. PubMed ID: 17046135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free Zn(2+) enhances inhibitory effects of EGCG on the growth of PC-3 cells.
    Sun SL; He GQ; Yu HN; Yang JG; Borthakur D; Zhang LC; Shen SR; Das UN
    Mol Nutr Food Res; 2008 Apr; 52(4):465-71. PubMed ID: 18324707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Zn2+ in epigallocatechin gallate affecting the growth of PC-3 cells.
    Chen X; Yu H; Shen S; Yin J
    J Trace Elem Med Biol; 2007; 21(2):125-31. PubMed ID: 17499153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physiological effect of conventional treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid on the LNCaP cell line.
    Richards LR; Jones P; Hughes J; Benghuzzi H; Tucci M
    Biomed Sci Instrum; 2006; 42():357-62. PubMed ID: 16817634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.
    Chuu CP; Chen RY; Kokontis JM; Hiipakka RA; Liao S
    Cancer Lett; 2009 Mar; 275(1):86-92. PubMed ID: 18977589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor.
    Thomas F; Patel S; Holly JM; Persad R; Bahl A; Perks CM
    Prostate; 2009 Feb; 69(2):219-24. PubMed ID: 18942120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
    Eom DW; Lee JH; Kim YJ; Hwang GS; Kim SN; Kwak JH; Cheon GJ; Kim KH; Jang HJ; Ham J; Kang KS; Yamabe N
    BMB Rep; 2015 Aug; 48(8):461-6. PubMed ID: 25441423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
    Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro.
    Zhang LC; Yu HN; Sun SL; Yang JG; He GQ; Ruan H; Shen SR
    Toxicol In Vitro; 2008 Jun; 22(4):953-60. PubMed ID: 18359184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
    Hastak K; Agarwal MK; Mukhtar H; Agarwal ML
    FASEB J; 2005 May; 19(7):789-91. PubMed ID: 15764647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LNCaP cells exposed to ceramic drug delivery treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid.
    Richards LR; Jones P; Hughes J; Benghuzzi H; Tucci M
    Biomed Sci Instrum; 2007; 43():242-7. PubMed ID: 17487088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
    Albrecht DS; Clubbs EA; Ferruzzi M; Bomser JA
    Chem Biol Interact; 2008 Jan; 171(1):89-95. PubMed ID: 17931610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
    Gupta S; Hussain T; Mukhtar H
    Arch Biochem Biophys; 2003 Feb; 410(1):177-85. PubMed ID: 12559991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
    Gupta S; Ahmad N; Nieminen AL; Mukhtar H
    Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
    Liu L; Ju Y; Wang J; Zhou R
    Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profile in human prostate LNCaP cancer cells by (--) epigallocatechin-3-gallate.
    Wang SI; Mukhtar H
    Cancer Lett; 2002 Aug; 182(1):43-51. PubMed ID: 12175522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.